420 related articles for article (PubMed ID: 19489439)
1. [Autosomal dominant macrothrombocytopenia with leukocyte inclusion bodies and MYH9 disorders].
Kunishima S
Rinsho Byori; 2009 Apr; 57(4):365-70. PubMed ID: 19489439
[TBL] [Abstract][Full Text] [Related]
2. [May-Hegglin anomaly: past and present--novel diagnostic test and new concept of the disease].
Kunishima S
Rinsho Byori; 2009 Jan; 57(1):54-9. PubMed ID: 19227191
[TBL] [Abstract][Full Text] [Related]
3. Identification of six novel MYH9 mutations and genotype-phenotype relationships in autosomal dominant macrothrombocytopenia with leukocyte inclusions.
Kunishima S; Matsushita T; Kojima T; Amemiya N; Choi YM; Hosaka N; Inoue M; Jung Y; Mamiya S; Matsumoto K; Miyajima Y; Zhang G; Ruan C; Saito K; Song KS; Yoon HJ; Kamiya T; Saito H
J Hum Genet; 2001; 46(12):722-9. PubMed ID: 11776386
[TBL] [Abstract][Full Text] [Related]
4. [May-Hegglin anomaly--from genome research to clinical laboratory].
Kunishima S
Rinsho Byori; 2003 Sep; 51(9):898-904. PubMed ID: 14560660
[TBL] [Abstract][Full Text] [Related]
5. Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes.
Heath KE; Campos-Barros A; Toren A; Rozenfeld-Granot G; Carlsson LE; Savige J; Denison JC; Gregory MC; White JG; Barker DF; Greinacher A; Epstein CJ; Glucksman MJ; Martignetti JA
Am J Hum Genet; 2001 Nov; 69(5):1033-45. PubMed ID: 11590545
[TBL] [Abstract][Full Text] [Related]
6. Advances in the understanding of MYH9 disorders.
Kunishima S; Saito H
Curr Opin Hematol; 2010 Sep; 17(5):405-10. PubMed ID: 20601875
[TBL] [Abstract][Full Text] [Related]
7. [Usefulness of immunofluorescence analysis of neutrophil nonmuscle myosin heavy chain-A for diagnosing in two sisters with May-Hegglin anomaly].
Kimura N; Matsumoto M; Matsumoto K; Asai N; Kunishima S
Rinsho Ketsueki; 2008 Dec; 49(12):1614-8. PubMed ID: 19110523
[TBL] [Abstract][Full Text] [Related]
8. MYH9-related platelet disorders.
Althaus K; Greinacher A
Semin Thromb Hemost; 2009 Mar; 35(2):189-203. PubMed ID: 19408192
[TBL] [Abstract][Full Text] [Related]
9. Perioperative management of MYH9 hereditary macrothrombocytopenia (Fechtner syndrome).
Selleng K; Lubenow LE; Greinacher A; Warkentin TE
Eur J Haematol; 2007 Sep; 79(3):263-8. PubMed ID: 17655694
[TBL] [Abstract][Full Text] [Related]
10. Identification of the first in cis mutations in MYH9 disorder.
Miyajima Y; Kunishima S
Eur J Haematol; 2009 Apr; 82(4):288-91. PubMed ID: 19191864
[TBL] [Abstract][Full Text] [Related]
11. Clinical manifestation and molecular genetic characterization of MYH9 disorders.
Provaznikova D; Geierova V; Kumstyrova T; Kotlin R; Mikulenkova D; Zurkova K; Matoska V; Hrachovinova I; Rittich S
Platelets; 2009 Aug; 20(5):289-96. PubMed ID: 19557653
[TBL] [Abstract][Full Text] [Related]
12. MYH9 spectrum of autosomal-dominant giant platelet syndromes: unexpected association with fibulin-1 variant-D inactivation.
Toren A; Rozenfeld-Granot G; Heath KE; Amariglio N; Rocca B; Crosson J; Epstein CJ; Laghi F; Landolfi R; Carlsson LE; Argraves S; Bizzaro N; Moxey-Mims M; Brok-Simoni F; Martignetti JA; Greinacher A; Rechavi G
Am J Hematol; 2003 Dec; 74(4):254-62. PubMed ID: 14635206
[TBL] [Abstract][Full Text] [Related]
13. Haematological characteristics of MYH9 disorders due to MYH9 R702 mutations.
Kunishima S; Yoshinari M; Nishio H; Ida K; Miura T; Matsushita T; Hamaguchi M; Saito H
Eur J Haematol; 2007 Mar; 78(3):220-6. PubMed ID: 17241369
[TBL] [Abstract][Full Text] [Related]
14. Cloning of the murine non-muscle myosin heavy chain IIA gene ortholog of human MYH9 responsible for May-Hegglin, Sebastian, Fechtner, and Epstein syndromes.
D'Apolito M; Guarnieri V; Boncristiano M; Zelante L; Savoia A
Gene; 2002 Mar; 286(2):215-22. PubMed ID: 11943476
[TBL] [Abstract][Full Text] [Related]
15. Identification of the first duplication in MYH9-related disease: a hot spot for unequal crossing-over within exon 24 of the MYH9 gene.
De Rocco D; Pujol-Moix N; Pecci A; Faletra F; Bozzi V; Balduini CL; Savoia A
Eur J Med Genet; 2009; 52(4):191-4. PubMed ID: 19450438
[TBL] [Abstract][Full Text] [Related]
16. High-resolution melting analysis for detection of MYH9 mutations.
Provaznikova D; Kumstyrova T; Kotlin R; Salaj P; Matoska V; Hrachovinova I; Rittich S
Platelets; 2008 Sep; 19(6):471-5. PubMed ID: 18925516
[TBL] [Abstract][Full Text] [Related]
17. MYH9 related platelet disorders - often unknown and misdiagnosed.
Althaus K; Najm J; Greinacher A
Klin Padiatr; 2011 May; 223(3):120-5. PubMed ID: 21567368
[TBL] [Abstract][Full Text] [Related]
18. Detection of unique neutrophil non-muscle myosin heavy chain-A localization by immunofluorescence analysis in MYH9 disorder presented with macrothrombocytopenia without leukocyte inclusions and deafness.
Kunishima S; Matsushita T; Shiratsuchi M; Ikuta T; Nishimura J; Hamaguchi M; Naoe T; Saito H
Eur J Haematol; 2005 Jan; 74(1):1-5. PubMed ID: 15613099
[TBL] [Abstract][Full Text] [Related]
19. Non-muscle myosin heavy chain IIA and IIB interact and co-localize in living cells: relevance for MYH9-related disease.
Marini M; Bruschi M; Pecci A; Romagnoli R; Musante L; Candiano G; Ghiggeri GM; Balduini C; Seri M; Ravazzolo R
Int J Mol Med; 2006 May; 17(5):729-36. PubMed ID: 16596254
[TBL] [Abstract][Full Text] [Related]
20. Renal manifestations of patients with MYH9-related disorders.
Han KH; Lee H; Kang HG; Moon KC; Lee JH; Park YS; Ha IS; Ahn HS; Choi Y; Cheong HI
Pediatr Nephrol; 2011 Apr; 26(4):549-55. PubMed ID: 21210153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
